Pharmaceutical Genomic Services / Genetic Analysis Services (DNA / RNA / Viral) play a pivotal role in modern drug development, enabling precise insights into the genetic and molecular mechanisms underlying disease and treatment response. These service providers offer advanced capabilities in sequencing, gene expression profiling, biomarker discovery, and viral genome analysis—supporting everything from early-stage research to companion diagnostics and personalized medicine initiatives. By outsourcing genomic and genetic analysis, pharmaceutical companies gain access to cutting-edge technologies, bioinformatics expertise, and scalable laboratory infrastructure, accelerating innovation while ensuring regulatory compliance and data integrity.